Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Information Architects (IARC): E-Commerce & EIP -- Ignore unavailable to you. Want to Upgrade?

To: Jack McKibben who wrote (3746)	12/16/1997 5:04:00 PM
From: sibe	Read Replies (2) \| Respond to of 10786

CHICAGO, Dec. 16 /PRNewswire/ -- The Chicago Board Options Exchange (CBOE) today announced it will begin trading options on three stocks. They are: Coulter Pharmaceuticals (Nasdaq: CLTR; CBOE: QCE) on Friday, December 19; and Alydaar Software Corporation (Nasdaq: SMTK; CBOE: QDY) and EntreMed, Inc. (Nasdaq: ENMD; CBOE: QMA) on Monday, December 22. Coulter Pharmaceuticals, located in Palo Alto, Calif., develops novel drugs and therapies for the treatment of cancer. QCE options will trade on the January expiration cycle, with introductory expirations in January, February, April and July. Initial strike prices have been set at 15, 17-1/2 and 20. (Note: strike prices are subject to change based on the price of the underlying security.) Coulter Pharmaceuticals options will trade in the Johnson & Johnson trading crowd. Alydaar Software Corporation, located in Charlotte, N.C., provides services to resolve the Year 2000 problem, as well as computer language translation and systems migration services. QDY options will trade on the February expiration cycle, with introductory expirations in January, February, May and August. Initial strike prices have been set at 12-1/2, 15 and 17-1/2. Alydaar Software Corporation options will trade in the Eastman Kodak trading crowd. EntreMed, Inc., located in Rockville, Md., researches and develops biopharmaceutical products that address the role of blood and blood vessels in the prevention of a broad range of diseases. QMA options will trade on the February expiration cycle, with introductory expirations in January, February, May and August. Initial strike prices have been set at 7-1/2, 10 and 12-1/2. Spear, Leeds & Kellogg has been named the Designated Primary Market Maker (DPM) in the options. CBOE, regulated by the Securities and Exchange Commission (SEC), is the pioneer of listed options and the world's largest options marketplace. SOURCE Chicago Board Options Exchange CO: Chicago Board Options Exchange; Coulter Pharmaceuticals; Alydaar Software Corporation; EntreMed, Inc. ST: Illinois IN: FIN SU: 12/16/97 16:41 EST prnewswire.com